LncRNA HULC/miR-556-5p Axis Attenuates Ang II-Induced CardiacMicrovascular Endothelial Cell Dysfunction by Suppressing theAMPK/FOXO3 Pathway

Key Points

• Improvement in endothelial cell function was observed through modulation of the LncRNA HULC/miR-556-5p axis, indicating therapeutic potential.
• Findings revealed a notable decrease in dysfunction metrics linked to angiotensin II exposure through specific pathway targeting.
• Investigation into endothelial cell injury utilized an observational analysis highlighting the AMPK/FOXO3 signaling pathway.
• Potential therapeutic avenues for heart failure management emerge, emphasizing the need for further exploration of the LncRNA HULC/miR-556-5p mechanisms.